Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients

CONTEXT: Currently there are no assays that can simultaneously quantify serum levels of the third-generation aromatase inhibitors (AIs): letrozole, anastrozole, and exemestane, and the ultra-low levels of estrogens in postmenopausal breast cancer patients on AI treatment. Such measurements may be pi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertelsen, Bjørn-Erik, Viste, Kristin, Helland, Thomas, Hagland, Magnus, Søiland, Håvard, Geisler, Jürgen, Lende, Tone Hoel, Lønning, Per Eystein, Sagen, Jørn V, Mellgren, Gunnar, Almås, Bjørg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016448/
https://www.ncbi.nlm.nih.gov/pubmed/34958096
http://dx.doi.org/10.1210/clinem/dgab923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016448/
https://www.ncbi.nlm.nih.gov/pubmed/34958096
http://dx.doi.org/10.1210/clinem/dgab923

Ejemplares similares